Stocks and Investing
Stocks and Investing
Fri, March 1, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
John McNulty Downgraded (CC) to Sell and Decreased Target to $19 on, Mar 1st, 2024
John McNulty of BMO Capital, Downgraded "The Chemours Company" (CC) to Sell and Decreased Target from $45 to $19 on, Mar 1st, 2024.
John has made no other calls on CC in the last 4 months.
There are 2 other peers that have a rating on CC. Out of the 2 peers that are also analyzing CC, 1 agrees with John's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Jeffrey Zekauskas of "JP Morgan" Maintained at Hold with Decreased Target to $26 on, Tuesday, November 7th, 2023
This is the rating of the analyst that currently disagrees with John
- Arun Viswanathan of "RBC Capital" Upgraded from Hold to Buy and Increased Target to $40 on, Friday, December 1st, 2023
Contributing Sources